← Eichor
Condition: Hidradenitis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hidradenitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa
Phase 2 · 1 location(s) · Sinocelltech Ltd. · NCT07244510A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participant
Phase 3 · 285 location(s) · AbbVie · NCT05889182Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis S
Phase 2 · 30 location(s) · Incyte Corporation · NCT07213973Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Phase 2 · 79 location(s) · Sanofi · NCT07170917A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Phase 2/Phase 3 · 58 location(s) · Bluefin Biomedicine, Inc. · NCT07287644Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa
Phase N/A · 1 location(s) · Peking Union Medical College · NCT07109765A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps
Phase 2 · 71 location(s) · Pfizer · NCT07228390A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx®
Phase 1 · 14 location(s) · UCB Biopharma SRL · NCT06888193A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers
Phase 1 · 1 location(s) · Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. · NCT06082323Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.
EARLY_Phase 1 · 1 location(s) · University of Alabama at Birmingham · NCT06326476Battlefield Acupuncture for Pain in Hidradenitis Suppurativa
NA · 1 location(s) · Wayne State University · NCT04218422Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
Phase N/A · 1 location(s) · University of California, San Francisco · NCT04115566Regulation of Inflammatory Genes in Hidradenitis Suppurativa
Phase N/A · 1 location(s) · University of Alabama at Birmingham · NCT05507125A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Sup
Phase 2 · 66 location(s) · Sanofi · NCT07225569A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Phase 2 · 41 location(s) · Navigator Medicines, Inc. · NCT07384975SAR447971 First-in-human Study
Phase 1 · 1 location(s) · Sanofi · NCT07629336A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T
Phase N/A · 10 location(s) · Sonoma Biotherapeutics, Inc. · NCT07123038Real-world Secukinumab Outcomes in Canadian HS Patients
Phase N/A · 15 location(s) · Novartis Pharmaceuticals · NCT07282015Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cose
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT07243782A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to S
Phase 1 · 1 location(s) · Shanghai Qilu Pharmaceutical Research and Development Center · NCT06946641A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo
Phase N/A · 116 location(s) · AbbVie · NCT07136467Global Healthcare Study on Hidradenitis Suppurativa
Phase N/A · 1 location(s) · Julia Tatjana Maul · NCT07659769A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Phase 2 · 49 location(s) · Takeda · NCT07244263A Study of LAD191 in Adults With Hidradenitis Suppurativa
Phase 2 · 1 location(s) · Almirall, S.A. · NCT07151937Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West: the C
Phase N/A · 13 location(s) · Nantes University Hospital · NCT04352036The Safety and Efficacy of Roflumilast Foam in HS
Phase 2 · 1 location(s) · Beth Israel Deaconess Medical Center · NCT07263230Evolution and Treatments of Chronic Inflammatory Systemic Diseases
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Besancon · NCT04191395Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients
Phase 3 · 4 location(s) · Institut Pasteur · NCT05821478Determinants of Chronic Inflammatory Skin Disease Trajectories
Phase N/A · 1 location(s) · University Hospital Schleswig-Holstein · NCT05928169Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adul
Phase N/A · 16 location(s) · Novartis Pharmaceuticals · NCT07543419
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.